ARTRYA Ltd Asset Resilience Ratio
ARTRYA Ltd asset resilience ratio. ARTRYA Ltd (AYA) has an Asset Resilience Ratio of 32.70% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of ARTRYA Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of ARTRYA Ltd (2022–2025)
Asset resilience ratio of ARTRYA Ltd from 2022 to 2025. This chart shows how ARTRYA Ltd's Asset Resilience Ratio has changed over time. Read ARTRYA Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down ARTRYA Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ARTRYA Ltd total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$30.15 Million | 32.7% |
| Total Liquid Assets | AU$30.15 Million | 32.70% |
Asset Resilience Insights
- Very High Liquidity: ARTRYA Ltd maintains exceptional liquid asset reserves at 32.70% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
ARTRYA Ltd Industry Peers by Asset Resilience Ratio
Compare ARTRYA Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medadvisor Ltd
AU:MDR |
Health Information Services | 12.37% |
|
Opyl Ltd
AU:OPL |
Health Information Services | 85.64% |
|
Global Health Ltd
AU:GLH |
Health Information Services | 9.84% |
|
Pathkey.ai Ltd
AU:PKY |
Health Information Services | 85.12% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 17.07% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
Alcidion Group Ltd
AU:ALC |
Health Information Services | 32.45% |
ARTRYA Ltd Asset Resilience Ratio by Year (2022–2025)
ARTRYA Ltd asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for ARTRYA Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.63% | AU$149.00K ≈ $105.43K |
AU$23.68 Million ≈ $16.75 Million |
-37.64pp |
| 2024-06-30 | 38.27% | AU$7.28 Million ≈ $5.15 Million |
AU$19.01 Million ≈ $13.45 Million |
+37.44pp |
| 2023-06-30 | 0.83% | AU$274.00K ≈ $193.87K |
AU$33.09 Million ≈ $23.41 Million |
-45.39pp |
| 2022-06-30 | 46.21% | AU$20.27 Million ≈ $14.35 Million |
AU$43.87 Million ≈ $31.04 Million |
-- |
About ARTRYA Ltd
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more